Charles Nelson is Chief Executive of Malaria Consortium, a UK-based international NGO delivering evidence-based health programmes that combat malaria and other target diseases (including NTDs, dengue, pneumonia, & malnutrition) and promote child and maternal health. Malaria Consortium currently works in 13 countries across Africa and South-East Asia, with more than 450 staff conducting implementation research, delivering selective large scale vector control and case management programmes, and providing technical assistance and consulting services to shape policy, promote best practice and deliver demonstrable value for money.
Charles was previously International Director at Merlin (Medical Emergency Relief International) overseeing the delivery of health and nutrition-focused emergency relief and longer term programmes through 5,000 staff in 16 countries worldwide. He joined the sector following nearly 30 years of experience in health systems design and reform, international business leadership and strategy consulting with a particular focus on healthcare systems and organisation, including supporting change in and across the UK National Health Service, working extensively on governance and evidence-based decision-making. As Global Head of Strategy and Markets’ Development for Mercer’s Health and Benefits’ business (part of the Marsh McClennan Corporation – MMC), Charles worked with major corporations and Government agencies around the world, launching and supporting emerging businesses particularly focused on health care financing and system integration. Charles also spent seven years with McKinsey & Company working on major strategy and change projects in the Healthcare and ‘Not-for-Profit’ sectors. A scientist by training, he began his career with 14 years in Operations/Logistics with various technical and line management roles with, among others; L’Oreal, GlaxoSmithkline, Northern Foods and Nabisco, including the manufacturing and distribution of medical and food products.